Published in Leukemia on March 01, 2007
The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther (2011) 4.39
Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc Natl Acad Sci U S A (2010) 3.00
Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer (2011) 2.41
A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell (2008) 2.38
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Mol Cancer Ther (2009) 2.31
Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol (2012) 2.27
Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res (2010) 2.11
Autophagy and tumorigenesis. FEBS Lett (2009) 1.76
EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One (2011) 1.73
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation. J Cell Mol Med (2010) 1.65
Autophagy and cancer. Exp Mol Med (2012) 1.57
Autophagy as a target for cancer therapy: new developments. Cancer Manag Res (2012) 1.44
Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. Neuro Oncol (2010) 1.27
Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J Biol Chem (2008) 1.25
Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev (2013) 1.25
Mitochondria directly donate their membrane to form autophagosomes during a novel mechanism of parkin-associated mitophagy. Cell Biosci (2014) 1.24
Unfolded protein response to autophagy as a promising druggable target for anticancer therapy. Ann N Y Acad Sci (2012) 1.21
Autophagy modulation for cancer therapy. Cancer Biol Ther (2011) 1.20
Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. J Biol Chem (2010) 1.17
Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. J Biol Chem (2010) 1.15
Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host Microbe (2011) 1.10
Autophagic pathways as new targets for cancer drug development. Acta Pharmacol Sin (2010) 1.05
c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. Hum Mol Genet (2014) 1.03
Metabolism addiction in pancreatic cancer. Cell Death Dis (2014) 1.02
Autophagy in blood cancers: biological role and therapeutic implications. Haematologica (2013) 0.99
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol Cancer (2013) 0.99
Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. J Exp Med (2015) 0.98
Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease. J Neurosci (2012) 0.96
c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells. J Transl Med (2011) 0.96
Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages. J Immunol (2012) 0.94
The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model. J Cancer (2013) 0.93
Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence. Cell Death Dis (2012) 0.93
Targeting autophagic pathways for cancer drug discovery. Chin J Cancer (2012) 0.91
Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia. Haematologica (2014) 0.90
New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev (2015) 0.90
Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells. Autophagy (2012) 0.89
Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro. Acta Pharmacol Sin (2012) 0.86
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance. Biologics (2008) 0.86
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors? Transl Oncol (2008) 0.82
Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects. PLoS Negl Trop Dis (2014) 0.81
Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation. Mol Pharm (2012) 0.81
Cellular prion protein (PrP(C)) and its role in stress responses. Int J Clin Exp Med (2015) 0.81
Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers. Biomol Ther (Seoul) (2015) 0.80
Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases? Int J Cell Biol (2012) 0.80
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/mTOR phosphorylation. Onco Targets Ther (2015) 0.80
Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells. PLoS One (2013) 0.80
Cardiomyocyte autophagy and cancer chemotherapy. J Mol Cell Cardiol (2013) 0.79
Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease. Antioxid Redox Signal (2014) 0.78
Autophagic flux inhibition and lysosomogenesis ensuing cellular capture and retention of the cationic drug quinacrine in murine models. PeerJ (2015) 0.78
Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J Virol (2012) 0.78
Modulating autophagy: a strategy for cancer therapy. Chin J Cancer (2011) 0.78
Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions. Drugs (2015) 0.77
Autophagy collaborates with ubiquitination to downregulate oncoprotein E2A/Pbx1 in B-cell acute lymphoblastic leukemia. Blood Cancer J (2015) 0.76
Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cells. Sci Rep (2016) 0.76
Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells. Oncol Lett (2016) 0.75
Gastrointestinal stromal tumors (GIST): facing cell death between autophagy and apoptosis. Autophagy (2017) 0.75
Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review. Curr Oncol (2015) 0.75
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 41.48
Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol (2001) 13.98
A protein conjugation system essential for autophagy. Nature (1998) 12.71
Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J Cell Biol (1999) 9.33
Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct (1998) 9.18
The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol (2000) 7.48
Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep (2001) 7.13
A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J Biol Chem (1998) 5.07
Autophagosome requires specific early Sec proteins for its formation and NSF/SNARE for vacuolar fusion. Mol Biol Cell (2001) 3.41
Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett (1995) 3.28
Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ (2007) 3.22
Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med (2000) 3.10
Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol (1998) 2.06
Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean-Congo hemorrhagic fever virus in the United Arab Emirates. Am J Trop Med Hyg (1996) 2.05
DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ (2008) 1.99
Is codon 129 of prion protein polymorphic in human beings but not in animals? Lancet (1997) 1.99
Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol (1999) 1.90
Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol (1998) 1.68
Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology (1995) 1.50
Rotavirus NSP4 induces a novel vesicular compartment regulated by calcium and associated with viroplasms. J Virol (2006) 1.49
Human SSAV-related endogenous retroviral element: LTR-like sequence and chromosomal localization to 18q21. Genomics (1989) 1.49
Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development. Leukemia (2005) 1.48
The late stages of autophagy: how does the end begin? Cell Death Differ (2009) 1.47
Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in HEp-2 cells. J Biol Chem (2000) 1.46
Travel-related Toscana virus infection. Lancet (1993) 1.43
Significance of restricted HIV expression for HIV neuropathogenesis: still an unresolved issue. AIDS (1997) 1.41
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol (1998) 1.36
Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats. Virology (2001) 1.36
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer. Br J Cancer (2005) 1.31
Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J (2001) 1.29
Oncogenic retrovirus from spontaneous murine osteomas. I. Isolation and biological characterization. J Gen Virol (1984) 1.29
Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines. Blood (2000) 1.29
Serosurvey and laboratory diagnosis of imported sandfly fever virus, serotype Toscana, infection in Germany. Epidemiol Infect (1995) 1.27
Genomic distribution and transcription of solitary HERV-K LTRs. Genomics (1993) 1.24
Immunoblot detection of antibodies to Toscana virus. J Med Virol (1996) 1.23
Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol (1995) 1.23
Heavy chain binding protein (BiP/GRP78) and endoplasmin are exported from the endoplasmic reticulum in rat exocrine pancreatic cells, similar to protein disulfide-isomerase. Arch Biochem Biophys (1992) 1.21
PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem (2001) 1.20
Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res Hum Retroviruses (1994) 1.20
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial. Br J Cancer (2005) 1.15
Transient host range selection for genetic engineering of modified vaccinia virus Ankara. Biotechniques (2000) 1.13
Vaccination with Rev and Tat against AIDS. Vaccine (1999) 1.11
Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia (2002) 1.11
Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature (1993) 1.09
Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology (1986) 1.09
Nested RT-PCR for detection of sandfly fever virus, serotype Toscana, in clinical specimens, with confirmation by nucleotide sequence analysis. Res Virol (1996) 1.08
Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Lett (1995) 1.07
Endogenous retroviral elements in human DNA. Cancer Res (1990) 1.07
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib. Leukemia (2006) 1.07
Gene expression during osteogenic differentiation in mandibular condyles in vitro. J Cell Biol (1990) 1.06
Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes. J Virol (1999) 1.06
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity. J Gen Virol (2001) 1.04
Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia. Leukemia (2005) 1.04
Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today (1997) 1.03
Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS (1992) 1.03
A mammary-specific promoter directs expression of growth hormone not only to the mammary gland, but also to Bergman glia cells in transgenic mice. Mol Endocrinol (1991) 1.03
Retracted Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Proc Natl Acad Sci U S A (1996) 1.03
Hepatitis C and arboviral antibodies in the island populations of Mauritius and Rodrigues. J Med Virol (1994) 1.02
HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS (1991) 1.02
Protein disulfide isomerase associates with misfolded human lysozyme in vivo. J Biol Chem (1994) 1.01
Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway. Oncogene (2009) 1.01
Infection of human fibroblasts and osteoblast-like cells with HIV-1. AIDS (1990) 1.00
Inhibitors of vacuolar-type H(+)-ATPase suppresses proliferation of cultured cells. J Cell Physiol (1993) 1.00
Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back. Leukemia (2003) 0.99
The SH2-containing adapter protein GRB10 interacts with BCR-ABL. Oncogene (1998) 0.97
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors. Cancer Gene Ther (1999) 0.97
Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J Invest Dermatol (1999) 0.97
HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J Immunol (1999) 0.97
Expression of antimicrobial peptides has an antitumour effect in human cells. Biochem Biophys Res Commun (1998) 0.96
Restricted expression of HIV1 in human astrocytes: molecular basis for viral persistence in the CNS. Res Virol (1995) 0.95
The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107. Leukemia (2005) 0.95
Monoclonal antibodies against diphtheria toxin fragment A. Characterization and introduction into living cells. Exp Cell Res (1984) 0.95
The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib. Leukemia (2013) 0.94
Aseptic meningitis caused by sandfly fever virus, serotype Toscana. Clin Infect Dis (1995) 0.94
Isolation of an SSAV-related endogenous sequence from human DNA. Virology (1986) 0.94
Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol (2000) 0.94
Stacks of flattened smooth endoplasmic reticulum highly enriched in inositol 1,4,5-trisphosphate (InsP3) receptor in mouse cerebellar Purkinje cells. Cell Struct Funct (1991) 0.94
Distribution of protein disulfide isomerase in rat hepatocytes. J Histochem Cytochem (1988) 0.93
Bone formation by osteoblast-like cells in a three-dimensional cell culture. Calcif Tissue Int (1990) 0.93
naf, a trans-regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region. J Virol (1990) 0.92
Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo. Leukemia (2003) 0.92
Acidification of phagosomes and degradation of rod outer segments in rat retinal pigment epithelium. Invest Ophthalmol Vis Sci (1994) 0.92
Diagnostic significance of quantitative determination of HIV antibody specific for envelope and core proteins. Lancet (1987) 0.92
Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumour virus and are of human endogenous origin. J Gen Virol (1992) 0.92
Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis. Blood (2001) 0.92
Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells. Oncogene (2008) 0.91
Characterization of the nucleational core complex responsible for mineral induction by growth plate cartilage matrix vesicles. J Biol Chem (1993) 0.91
S71 is a phylogenetically distinct human endogenous retroviral element with structural and sequence homology to simian sarcoma virus (SSV). Virology (1990) 0.91
Localization of protein disulfide isomerase on plasma membranes of rat exocrine pancreatic cells. J Histochem Cytochem (1988) 0.91
Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein. J Cell Sci (2001) 0.91
Mechanism of matrix vesicle calcification: characterization of ion channels and the nucleational core of growth plate vesicles. Bone Miner (1992) 0.90
Expression of protooncogenes in murine osteosarcomas. Int J Cancer (1986) 0.90
The tyrosine kinase inhibitor CGP 57148 (ST1 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X. Clin Cancer Res (2000) 0.89
Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection. J Physiol Pharmacol (2001) 0.88